Arthur A. Levin
CIK: 0001181556
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (24 total)
- Jun 3, 2026STOK
Stoke Therapeutics, Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
17.8K shares- - Mar 13, 2026STOK
Stoke Therapeutics, Inc.
Sale(S)Direct605 shares at avg. $36.80$22K - Feb 27, 2026RNAM
Avidity Biosciences, Inc.
Disposition(D)Direct16.6K shares- - Feb 27, 2026RNAM
Avidity Biosciences, Inc.
Disposition(D)Indirect131.4K shares- - Jan 21, 2026RNA
Avidity Biosciences, Inc.
Sale(S)Direct1.8K shares at avg. $72.45$127K - Dec 31, 2025STOK
Stoke Therapeutics, Inc.
Exercise(M)Direct1.2K shares- - Dec 19, 2025RNA
Avidity Biosciences, Inc.
Gift(G)Direct1.3K shares- - Sep 30, 2025STOK
Stoke Therapeutics, Inc.
Exercise(M)Direct1.2K shares- - Aug 6, 2025RNA
Avidity Biosciences, Inc.
Exercise(M)Direct107.5K shares at avg. $22.34$2.4M - Aug 6, 2025RNA
Avidity Biosciences, Inc.
Sale(S)Direct107.5K shares at avg. $47.62$5.1M - Jun 30, 2025STOK
Stoke Therapeutics, Inc.
Exercise(M)Direct1.2K shares- - Jun 10, 2025RNA
Avidity Biosciences, Inc.
Award(A)Direct6.7K shares- - Jun 3, 2025STOK
Stoke Therapeutics, Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
29.7K shares- - Mar 31, 2025STOK
Stoke Therapeutics, Inc.
Exercise(M)Direct1.2K shares- - Mar 19, 2025STOK
Stoke Therapeutics, Inc.
Award(A)DirectRestricted Stock Units
4.8K shares- - Jan 21, 2025RNA
Avidity Biosciences, Inc.
Sale(S)Direct1.9K shares at avg. $28.60$54K - Nov 19, 2024RNA
Avidity Biosciences, Inc.
Sale(S)Direct3.3K shares at avg. $42.12$140K - Nov 19, 2024RNA
Avidity Biosciences, Inc.
Exercise(M)Direct3.3K shares at avg. $1.24$4K - Oct 21, 2024RNA
Avidity Biosciences, Inc.
Exercise(M)Direct5K shares at avg. $1.24$6K - Oct 21, 2024RNA
Avidity Biosciences, Inc.
Sale(S)Direct5K shares at avg. $46.63$233K - Sep 19, 2024RNA
Avidity Biosciences, Inc.
Sale(S)Direct5K shares at avg. $45.73$229K - Sep 19, 2024RNA
Avidity Biosciences, Inc.
Exercise(M)Direct5K shares at avg. $1.24$6K - Sep 6, 2024RNA
Avidity Biosciences, Inc.
Gift(G)Indirect22.5K shares- - Sep 6, 2024RNA
Avidity Biosciences, Inc.
Gift(G)Indirect22.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 3, 2026 |  STOK Stoke Therapeutics, Inc. | Award(A) Director Stock Option (Right to Buy) | 17,786 | - | - | Direct |
| Mar 13, 2026 | STOK Stoke Therapeutics, Inc. | Sale(S) | 605 | $36.80 | $22,264 | Direct |
| Feb 27, 2026 |  RNAM Avidity Biosciences, Inc. | Disposition(D) | 16,562 | - | $0 | Direct |
| Feb 27, 2026 | RNAM Avidity Biosciences, Inc. | Disposition(D) | 131,372 | - | $0 | Indirect |
| Jan 21, 2026 |  RNA Avidity Biosciences, Inc. | Sale(S) | 1,758 | $72.45 | $127,367 | Direct |
| Dec 31, 2025 | STOK Stoke Therapeutics, Inc. | Exercise(M) | 1,211 | - | $0 | Direct |
| Dec 19, 2025 | RNA Avidity Biosciences, Inc. | Gift(G) | 1,330 | - | - | Direct |
| Sep 30, 2025 | STOK Stoke Therapeutics, Inc. | Exercise(M) | 1,211 | - | - | Direct |
| Aug 6, 2025 | RNA Avidity Biosciences, Inc. | Exercise(M) | 107,500 | $22.34 | $2,401,550 | Direct |
| Aug 6, 2025 | RNA Avidity Biosciences, Inc. | Sale(S) | 107,500 | $47.62 | $5,118,881 | Direct |
| Jun 30, 2025 | STOK Stoke Therapeutics, Inc. | Exercise(M) | 1,210 | - | - | Direct |
| Jun 10, 2025 | RNA Avidity Biosciences, Inc. | Award(A) | 6,692 | - | - | Direct |
| Jun 3, 2025 | STOK Stoke Therapeutics, Inc. | Award(A) Director Stock Option (Right to Buy) | 29,747 | - | - | Direct |
| Mar 31, 2025 | STOK Stoke Therapeutics, Inc. | Exercise(M) | 1,210 | - | - | Direct |
| Mar 19, 2025 | STOK Stoke Therapeutics, Inc. | Award(A) Restricted Stock Units | 4,842 | - | - | Direct |
| Jan 21, 2025 | RNA Avidity Biosciences, Inc. | Sale(S) | 1,872 | $28.60 | $53,537 | Direct |
| Nov 19, 2024 | RNA Avidity Biosciences, Inc. | Sale(S) | 3,323 | $42.12 | $139,973 | Direct |
| Nov 19, 2024 | RNA Avidity Biosciences, Inc. | Exercise(M) | 3,323 | $1.24 | $4,121 | Direct |
| Oct 21, 2024 | RNA Avidity Biosciences, Inc. | Exercise(M) | 5,000 | $1.24 | $6,200 | Direct |
| Oct 21, 2024 | RNA Avidity Biosciences, Inc. | Sale(S) | 5,000 | $46.63 | $233,168 | Direct |
| Sep 19, 2024 | RNA Avidity Biosciences, Inc. | Sale(S) | 5,000 | $45.73 | $228,658 | Direct |
| Sep 19, 2024 | RNA Avidity Biosciences, Inc. | Exercise(M) | 5,000 | $1.24 | $6,200 | Direct |
| Sep 6, 2024 | RNA Avidity Biosciences, Inc. | Gift(G) | 22,500 | - | $0 | Indirect |
| Sep 6, 2024 | RNA Avidity Biosciences, Inc. | Gift(G) | 22,500 | - | $0 | Indirect |
1-24 of 24 transactions
About LEVIN ARTHUR A
LEVIN ARTHUR A (SEC CIK 0001181556) files insider reports with the SEC as Director of Stoke Therapeutics, Inc. (STOK) and Director of Avidity Biosciences, Inc. (RNAM).
Signal8 holds 18 ownership filings by LEVIN ARTHUR A, all Form 4s, filed between Sep 10, 2024 and Jun 5, 2026. Those filings report 24 transactions, from Sep 6, 2024 to Jun 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on LEVIN ARTHUR A's filings is in BEDFORD, MA.
Recent filings by LEVIN ARTHUR A
- Jun 3, 2026: Grant or award of STOK derivative securities (Form 4, code A).
- Mar 13, 2026: Open-market sale of STOK shares (Form 4, code S).
- Feb 27, 2026: Disposition to issuer transactions of RNAM shares (2 lines, Form 4, code D).
- Jan 21, 2026: Open-market sale of RNA shares (Form 4, code S).
- Dec 31, 2025: Option exercise of STOK shares (Form 4, code M).
Other insiders filing for Stoke Therapeutics, Inc. (STOK)
- Allan Jonathan, GENERAL COUNSEL & CORP SEC
- Ticho Barry, CHIEF MEDICAL OFFICER
- Cumbo Alexander, Director
- Kaye Edward M. MD, Director
- Harrison Seth Loring, Director
- McCauley Thomas, Chief Scientific Officer